ResMed's Management Hosts Deutsche Bank AG Health Care Conference Call (Transcript)

ResMed Inc. (RMD)

Deutsche Bank AG Health Care Conference Call

May 8, 2012 10:00 am EDT

Executives

David Pendarvis – Chief Administrative Officer and Global General Counsel

Analysts

David Low – Deutsche Bank

Presentation



David Low – Deutsche Bank

Compare to:
Previous Statements by RMD
» ResMed's CEO Discusses Q3 2012 Results - Earnings Call Transcript
» ResMed's CEO Discusses F2Q12 Results - Earnings Call Transcript
» ResMed's CEO Discusses F1Q 2012 Results - Earnings Call Transcript
» ResMed's CEO Discusses Q4 2011 Results - Earnings Call Transcript

Good morning, everyone. My name is David Low. I cover Healthcare stocks out of Australia, including ResMed, which has obviously got dual listing. Today, we've got David Pendarvis, who is the Chief Administrative Officer at ResMed. David's got ten years' experience at ResMed. And he's going to give us a presentation and then take a few questions. Thanks very much, David.

David Pendarvis

Fantastic. Thank you, David, and thanks to Deutsche Bank for having us, and for covering the ResMed both here, obviously, and down on the Australian Stock Exchange, where we are dual listed. So, the forward-looking statements, obviously, hold on to your seat belts when we predict things, we can at sometimes be wrong. And I want to really focus on sort of three main points here.

If you take nothing else away from this presentation, it's that ResMed really is sort of the Holy Grail of healthcare, in the sense that we do three things, we prevent disease, in particular the disease of sleep apnea and we improve the quality of life.

But, we also reduced the cost of health care. So, as systems around the world are trying to struggle with delivering higher quality for less cost. We do that and we do that in this space. So, those are really the three primary things that ResMed delivers here.

1 2 3 Next › Last »